Aceto acquires A&C Bio Buffer, expanding biopharma capabilities
Deal is expected to boost manufacturer’s European presence, Aceto executives say
Cambrex to invest $30M toward manufacturing center expansion
Among areas, financial commitment will power clinical and commercial manufacturing suites
AmerisourceBergen supports worldwide Covid vaccine distribution
Via its supply chain network, drug wholesaler has helped deliver more than 75 million vaccines
Global cold-chain expansions include ultracold storage, more packaging capacity
Marken/UPS, LifeScience Logistics and Packaging Technology Group are among the latest contenders
Moderna to build mRNA facility in Africa
Company officials predict 500 million vaccine doses per year to be produced via the center, which will offer fill-finish, packaging services
Science 37 begins trading on Nasdaq
Previous merger earns clinical research company $235 million as it looks to advance patient enrollment
Peli BioThermal moves its American HQ
Company officials believe new facility will help meet ongoing demand for temperature-controlled packaging
Syneos Health inks deal for RxDataScience
Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization
Report: Covid vaccine boosters, children’s doses ought to be outsourced
Pace of production plays a major role, says study
Thermo Fisher opens Swiss biologics site
Manufacturing facility to provide 1.5 million square feet of bioproduction technologies
Moderna to construct science center in Cambridge, MA
Will feature laboratories intended for R&D
People spotlight — September 2021
The latest people news happenings over the past month
New temperature indicator targets vaccine wastage
Can monitor vials for temperature breaches at any point in cold chain, developer says
Genentech, Lifelink Systems form patience experience partnership
Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers
Siemens Healthineers plans to invest over $32M in site expansion
Development of additional 29,000 square feet addresses med tech company’s internal production capabilities
Biosimilars gain traction with regulators, manufacturers
Recent FDA actions may finally usher in access boost to follow-on biologics in the US
AstraZeneca invests in self-amplifying RNA
R&D partnership with VaxEquity outlines plan to use saRNA as a go-to therapeutic
Maersk to debut carbon neutral pharma warehouse
Polish facility will be based on GDP and ISO practices
AstraZeneca to invest $360M in API manufacturing plant
Financial commitment expected to expand the development and commercialization pipeline for new medicines
Tower Cold Chain Solutions opens new headquarters
UK location offers close proximity to London Heathrow Airport
Pfizer-BioNTech vaccine trial presents positive results in children ages 5-11 years old
Side effects were consistent with 16-25 age group
Health Canada approves Pfizer, Moderna Covid vaccines in individuals 12 and older
Both Comirnaty, Spikevax jabs had previously been authorized for use under Interim Order
Catalent and Phathom Pharmaceuticals sign commercial supply agreement
Deal is dependent on FDA approval of Phathom’s vonoprazan compound
JLL Life Sciences Real Estate Outlook: Boom times continue for Boston metro area
Availability of space for new labs is a key selling point
Syneos Health purchases StudyKIK
Acquisition expected to help provide customers with a quicker clinical trial recruitment process
Emergent, Providence Therapeutics ink vaccine manufacturing agreement
Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot
AGC Biologics grows pDNA, mRNA production abilities at Heidelberg site
Expansion at German facility features new GMP manufacturing lines and a cleanroom, among other additions
Thermo Fisher to build Nashville single-use technology manufacturing site
Latest construction plan continues CDMO’s vision for biopharma expansion
HDA calls for withdrawal of FDA’s latest DSCSA guidance on the ‘enhanced drug distribution system’
FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance
Report: BioNTech to seek vaccine approval for 5 to 11-year-olds over the ‘next few weeks’
Biotech firm to file regulatory dossier with officials around the world
